MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • 2022 International Congress

    Improving Dual Task Walking Control after Training with Internal-focus Strategy in Parkinson Disease with Freezing of Gait

    SH. Yu, CY. Huang, CH. Sheu, RM. Wu, YC. Liao (Taipei, Taiwan)

    Objective: To investigate the dual task walking training effects with different attentional focus strategies in patient with Parkinson’s Disease (PD) who had freezing of gait…
  • 2022 International Congress

    May apomorphine be helpful for the axial symptoms of Parkinson’s Disease?

    A. Alonso-Canovas, P. Perez Torre, G. Sanchez Diez, A. Patiño Paton, N. Gonzalez, I. Parees Moreno, JC. Martinez Castrillo (Madrid, Spain)

    Objective: To assess the effect of continuous subcutaneous infusion of apomorphine on axial symptoms of Parkinson Disease. Background: Axial symptoms of Parkinson’s Disease may be…
  • 2022 International Congress

    Effects of directional subthalamic deep brain stimulation on gait and balance in Parkinson Disease patients.

    S. Cherif, C. Olivier, J. Bourilhon, D. Bannier, D. Maltête, B. Lau, S. Derrey, E. Bardinet, C. Karachi, M. Welter (Paris, France)

    Objective: To assess the effects of directional STN-DBS on gait and balance in PD patients Background: STN-DBS is efficient to treat motor signs in PD…
  • 2022 International Congress

    The acceptability of wearable devices to measure mobility in people with Parkinson’s Disease: observations from Mobilise-D

    A. Keogh, L. Alcock, P. Brown, M. Brozgol, E. Gazit, C. Hansen, J. Hausdorff, W. Maetzler, L. Rochester, A. Yarnall, B. Caulfield (Dublin, Ireland)

    Objective: To explore the acceptability of wearable devices to remotely measure mobility in the Mobilise-D technical validation study (TVS). Background: When deploying tools to monitor…
  • 2022 International Congress

    The effects of on-demand auditory cueing on home-based freezing of gait in people with Parkinson’s disease

    D. Zoetewei, T. Herman, L. Palmerini, A. Ferrari, J. Hausdorff, A. Nieuwboer, P. Ginis (Leuven, Belgium)

    Objective: To evaluate the effects of on-demand auditory cueing on video-rated freezing of gait (FOG) during home-based FOG-provoking tests in people with Parkinson’s disease. Background:…
  • 2022 International Congress

    Effect of rehabilitation interventions on freezing of gait in people with Parkinson’s disease: a systematic review and meta-analyses

    L. Goh, C. Canning, J. Song, L. Clemson, N. Allen (Camperdown, Australia)

    Objective: To summarize the effects of rehabilitation interventions to reduce freezing of gait (FOG) in people with Parkinson’s disease (PwPD). Background: FOG is a debilitating…
  • 2022 International Congress

    Dynamical modulations of low frequency deep brain stimulation on axial symptoms in Parkinson’s disease

    Y. Thenaisie, L. Comeliau, C. Varescon, L. Asboth, M. Castro, J. Bally, G. Courtine, J. Bloch, E. Martin Moraud (Lausanne, Switzerland)

    Objective: First, we aimed to evaluate the optimal contact to address axial symptoms with low frequency deep brain stimulation (LFS). Second, we aimed to evaluate…
  • 2022 International Congress

    Alprazolam reduces freezing of gait and improves freezing-related gait measures

    A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Impact of botulinum toxin treatment on gait in focal dystonia

    J. Cuinat, B. Debu, P. Pelissier, A. Castrioto, S. Meoni, S. Potel, V. Fraix, E. Moro (Grenoble, France)

    Objective: To study the effects of botulinum neurotoxin (BTX) treatment on gait characteristics in patients with blepharospasm and cervical dystonia. Background: The impact of focal…
  • 2022 International Congress

    Relationship between gait speed and functional measurements in Parkinson’s disease

    D. Iucksch, B. Yamaguchi, L. Araujo, V. Israel (CURITIBA, Brazil)

    Objective: The present study aims to relate gait speed in Parkinson's disease (PD) with functional measures of muscle strength, balance and physical capacity. Background: PD…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 30
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley